Publicacions en col·laboració amb investigadors/es de Complejo Hospitalario Universitario de Albacete (9)

2019

  1. PDGF-BB serum levels are decreased in adult onset Pompe patients

    Scientific Reports, Vol. 9, Núm. 1

  2. Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT

    Molecular Genetics and Metabolism, Vol. 128, Núm. 1-2, pp. 129-136

2018

  1. Quantitative muscle MRI to follow up late onset Pompe patients: A prospective study

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Observational Study of Switching from Natalizumab to Immunomodulatory Drugs

    European Neurology, Vol. 77, Núm. 3-4, pp. 130-136

2016

  1. Muscle MRI findings in childhood/adult onset pompe disease correlate with muscle function

    PLoS ONE, Vol. 11, Núm. 10

2010

  1. Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells

    Biochemical Pharmacology, Vol. 79, Núm. 2, pp. 239-250

2008

  1. Farmacología de la neuroprotección en el ictus isquémico agudo

    Revista de Neurologia, Vol. 47, Núm. 5, pp. 253-260

  2. Is good old minocycline a new neuroprotective drug?

    Revista de Neurologia, Vol. 47, Núm. 1, pp. 31-38

2006

  1. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression

    Neurobiology of Disease, Vol. 24, Núm. 2, pp. 296-307